ArticleMedical oncology (Northwood, London, England)2022

MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.

Qiang Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.